Gall-bladder and colonic opacification following parenteral ioxaglate.
Of 50 successive in-patients with normal blood urea levels who received ioxaglate (Hexabrix 320; May & Baker Ltd), 60% showed gall-bladder opacification 12-25 h later. None of these patients had been asked to fast after receiving the ioxaglate. This has not been reported previously with any of the presently available urographic media, either conventional or the new low-osmolality agents. This should be regarded as a normal occurrence and does not imply impairment of renal function.
D000328:Adult; D000368:Aged; D003106:Colon / Q000378:metabolism*; D003287:Contrast Media / Q000008:administration & dosage / Q000378:metabolism*; D005704:Gallbladder / Q000378:metabolism*; D006801:Humans; D007263:Infusions, Parenteral; D007463:Iodobenzoates / Q000378:metabolism*; D007485:Ioxaglic Acid; D008875:Middle Aged; D014283:Triiodobenzoic Acids / Q000008:administration & dosage / Q000378:metabolism*
D003287:Contrast Media; D007463:Iodobenzoates; D014283:Triiodobenzoic Acids; D007485:Ioxaglic Acid